![Trisha Wise Draper with Vinita Takiar in a lab](https://www.uc.edu/news/articles/2024/03/n21232876/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1709758085356.jpg)
WDTN Dayton news: FDA approves first melanoma cellular therapy
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, spoke with WDTN Dayton to discuss the approval of Amtagvi, the first cellular therapy for metastatic or unresectable melanoma, a harmful skin cancer.
“It’s actually a cellular therapy but its very different than the cellular therapies that are currently available for a lot of the hematologic malignancies,” said Wise-Draper, a University of Cincinnati Cancer Center member, section head of Medical Oncology and professor in the Division of Hematology/Oncology in UC’s College of Medicine.
The new therapy is for patients who have exhausted all other options.
“Because of the complicated nature of it, not everyone should get the therapy,” Wise-Draper said. “But for those that are fit and able to undergo the multiple treatments, cause it does require a very large multidisciplinary team.”
Wise-Draper said the Cancer Center's team of multidisciplinary experts will evaluate each patient to see if they are a fit for Amtagvi, since it is extensive.
“It’s really important that we evaluate the patient for feasibility upfront,” she said, “and make sure that’s something they’ll be able to undergo.”
Featured photo at top of Wise-Draper, left, and Vinita Takiar in their research laboratory. Photo/Colleen Kelley/UC Marketing + Brand
Related Stories
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
Journal-News: UC studies art, pet robot therapy
February 7, 2022
The Journal-News featured the research of Dr. Soma Sengupta, Dr. Claudia Rebola and Dr. Meera Rastogi, who have developed an art therapy app and pet robot study to see how the interventions can affect the mental health of patients with vestibular schwannomas.
55KRC: UC researchers examine role of stress in Parkinson's disease
March 8, 2022
University of Cincinnati researchers Kim Seroogy, Teresa Reyes and James Herman were featured on 55KRC's Simply Medicine program to discuss their research into the role of stress in Parkinson's disease.
Enquirer: Experts discuss reasons for drop in overdose deaths
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
Jacksonville media: New stroke research aims to help predict recovery
April 18, 2023
Jacksonville, Florida television news station WJXT highlighted the VERIFY study being led by University of Cincinnati researchers that will examine if certain biomarkers can predict the likelihood that a patient will recover motor functions following a stroke.
Know Stroke Podcast: UC physician discusses mobile stroke unit
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
Physics World names UC, Cincinnati Children's study among top 10 Breakthroughs of 2022
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.